In fact, patients with chronic-stage CML have many CD34+ leukemia cells with innate resistance to imatinib at the time of diagnosis (Perrotti et al., 2010; Pascu VÎnturiŞ and GĂman, 2020). Here, CD34 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.